LON:JPGI Jpmorgan Global Growth & Income (JPGI) Share Price, News & Analysis → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free JPGI Stock Alerts GBX 340 -10.00 (-2.86%) (As of 02/25/2020) Add Compare Share Share Today's Range 338▼ 35550-Day Range 340▼ 34052-Week Range 298▼ 368Volume573,564 shsAverage Volume198,904 shsMarket Capitalization£472.52 millionP/E Ratio5.01Dividend Yield0.04%Price TargetN/A Stock AnalysisStock Analysis Get Jpmorgan Global Growth & Income alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Jpmorgan Global Growth & Income Stock (LON:JPGI)JPMorgan Global Growth & Income plc is a closed-ended equity mutual fund launched and managed by JPMorgan Funds Limited. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations, with a bias towards large cap companies. It benchmarks the performance of its portfolio against the MSCI All Countries World (NR) Index. The fund was formerly known as JPMorgan Overseas Investment Trust plc. JPMorgan Global Growth & Income plc was formed on December 25, 1887 and is domiciled in the United Kingdom.Read More JPGI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JPGI Stock News HeadlinesApril 13, 2024 | msn.comJPMorgan Crushes Earnings Expectations Despite Global Chaos!April 12, 2024 | markets.businessinsider.comJPMorgan Q1 Profit Up 6%, Results Top EstimatesApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 11, 2024 | markets.businessinsider.comJPMorgan Chase earnings preview: what Wall Street is expectingApril 10, 2024 | msn.comJPMorgan CEO warns interest rates could rise to 8 percent ‘or even more’April 9, 2024 | msn.comExpect upto 8% interest rates in US: JP Morgan Chase's Jamie DimonApril 8, 2024 | msn.comEuropean losers of higher financing costs - JPMorganApril 2, 2024 | msn.comSentiment and positioning indicators are near highs, JPMorgan warnsApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 1, 2024 | msn.comJPMorgan's Latest Market Guide: US Economy Shows Resilience Amid Rapid ChangesMarch 13, 2024 | bloomberg.comGold Is JPMorgan’s Top Pick in Commodities With Price Eyeing $2,500March 13, 2024 | seekingalpha.comDD And JJ: Two Preferred Stocks Available From JPMorgan ChaseFebruary 18, 2024 | msn.comJPMorgan To Pay Over $350 Million For Trade-Reporting LapsesFebruary 12, 2024 | benzinga.comJPMorgan Chase & Co. Reports Mixed Financial Performance Amidst Economic HeadwindsFebruary 6, 2024 | msn.comJPMorgan Chase plans to open over 500 branches in multibillion-dollar expansionFebruary 6, 2024 | nasdaq.comJPMorgan (JPM), Others Clinch Victory in Treasury Rigging CaseFebruary 6, 2024 | msn.comJPMorgan to open more than 500 new bank branches over next three yearsJanuary 25, 2024 | reuters.comKey executives at JPMorgan taking on new rolesJanuary 23, 2024 | msn.comJPMorgan Remains Bearish On S&P 500 Despite Record Highs: 'Lackluster' Earnings, Elevated Valuations Raise Red FlagsJanuary 12, 2024 | barrons.comJPMorgan Reports Earnings Miss, Stock RisesJanuary 12, 2024 | msn.comJP Morgan earnings miss forecasts on $3 billion FDIC bank-rescue payoutJanuary 12, 2024 | msn.comJPMorgan Chase reports its most profitable year everJanuary 9, 2024 | msn.comBank Earnings Are Friday. Why This Analyst Likes JPMorgan, Downgrades Wells Fargo.January 5, 2024 | msn.comJPMorgan, Bank of America lead earnings parade of U.S. largest banks to cap off tough yearJanuary 4, 2024 | msn.comJP Morgan Downgrades Prudential Financial (PRU)December 30, 2023 | seekingalpha.comJPMorgan: When Investors Start To Chase, It's Time To Brace (Downgrade)December 19, 2023 | msn.comIs JPMorgan (JPM) Stock Likely to Have Impressive 2024 Too?See More Headlines Receive JPGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jpmorgan Global Growth & Income and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinance Industry Asset Management Sub-IndustryN/A Current SymbolLON:JPGI Previous SymbolLON:JMO CUSIPN/A CIKN/A Webam.jpmorgan.com Phone+44-20-72825555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio5.01 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.41 Current Ratio21.68 Quick Ratio20.90 Sales & Book Value Annual Sales£93.27 million Price / Sales5.07 Cash FlowGBX 26.71 per share Price / Cash Flow12.73 Book ValueGBX 347.90 per share Price / Book0.98Miscellaneous Outstanding Shares138,976,000Free FloatN/AMarket Cap£472.52 million OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Ed WalkerLead Investment Mang.Mr. Howard Williams (Age 59)Head of the Global Equities and Portfolio Mang. Mr. Jeroen Karel Huysinga (Age 55)Portfolio Mang. Key CompetitorsRiverstone EnergyLON:RSEBH GlobalLON:BHGGPollen StreetLON:HONYArrow Global GroupLON:ARWPolar CapitalLON:POLRView All Competitors JPGI Stock Analysis - Frequently Asked Questions How have JPGI shares performed in 2024? Jpmorgan Global Growth & Income's stock was trading at GBX 340 at the beginning of the year. Since then, JPGI stock has increased by 0.0% and is now trading at GBX 340. View the best growth stocks for 2024 here. Is Jpmorgan Global Growth & Income a good dividend stock? Jpmorgan Global Growth & Income (LON:JPGI) pays an annual dividend of GBX 0.13 per share and currently has a dividend yield of 3.96%. JPGI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 0.19%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for JPGI. What other stocks do shareholders of Jpmorgan Global Growth & Income own? Based on aggregate information from My MarketBeat watchlists, some companies that other Jpmorgan Global Growth & Income investors own include JPMorgan Claverhouse (JCH), Worldwide Healthcare (WWH), Diageo (DGE), Scottish Mortgage (SMT), Prudential (PRU), Polar Capital Technology Trust (PCT) and Legal & General Group (LGEN). How do I buy shares of Jpmorgan Global Growth & Income? Shares of JPGI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:JPGI) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jpmorgan Global Growth & Income PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.